Abstract
In 1978, David Kemp published a paper that demonstrated a new auditory phenomenon, OAEs. Since then, OAE research expanded broadly, with continued contributions by Kemp. Significantly, Kemp and his colleagues early-on developed commercially-available equipment. Used in the default settings, the equipment was good for hearing screening. But those who wanted to dig deeper could set up solid clinical-research protocols. This allowed translational and clinical research to progress alongside basic research. While OAEs are most often used clinically as pass/fail hearing-screening or site-of-lesion tests, Kemp at the outset inspired other uses, including detection of cochlear changes. He laid out critically important principles that have served as cornerstones for applied OAE research in the area of noise exposure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
